Advocacy Related Public Policies

Updated February 22, 2011

Autopsy

• Restrictions on the Uses of Autopsy Materials

Clinical Laboratory Improvement Amendments (CLIA)

• Criteria for the Clinical Laboratory Director
• CLIA Waived Tests and Test Categories
• Point of Care Testing
• Retention of Laboratory Records and Materials

Genetic Medicine

• Statement on Patents and Gene-Based Tests

Health Care Delivery

• Licensure Requirements for Interstate Diagnosis/Treatment

Health System Reform

• Antitrust Reform
• Medical Liability Reform

Health Insurance

• Health Care Coverage and Financing

Payment and Reimbursement

• Payment and Performance of the Autopsy Service
• Direct Payment for Pathology Services
• Pathologist Professional Component Billing for Clinical Pathology Services

Pap Test

• Frequency of Cervical Cancer Screening
• Guidelines for the Review of Pap Tests in the Context of Litigation or Potential Litigation
• Third Party Payment for Pap Tests

Patient Safety

• Patient Safety and Informing Patients of Pathology Errors
• Patient Safety
• Definition of Quality Assurance, Quality Control, and Quality Improvement

Scope of Practice

• Determination of Appropriate Clinical and Anatomic Laboratory Services
• Anatomic Pathology Scope of Practice
• Pharmacist Scope of Practice and Laboratory Testing Responsibility

Related Links

• Testimony to Congress
• Letters to policymakers
• Regulatory comments
• Information Packets
• Statline